| CSL Stock | | | 273.72 0.58 0.21% |
Insider
Paul McKenzie is Chief Officer of CSL
| Age | 58 |
| Address | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 |
| Phone | 61 3 9389 1911 |
| Web | https://www.csl.com.au |
CSL Management Efficiency
The company has return on total asset
(ROA) of
0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1458 %, meaning that it generated $0.1458 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CSL's
Total Current Liabilities is comparatively stable compared to the past year.
Liabilities And Stockholders Equity is likely to gain to about 59.8
B in 2024, whereas
Change To Liabilities is likely to drop slightly above 176
M in 2024.
CSL (CSL) is traded on Australian Securities Exchange in Australia and employs 32,698 people. CSL is listed under Biotechnology category by Fama And French industry classification.
Management Performance
CSL Leadership Team
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kate Priestman, Chief Officer | |
| Paul McKenzie, Chief Officer | |
| Chris Cooper, Head Relations | |
| Andy Schmeltz, Executive Unit | |
| Jeffrey Ball, First Officer | |
| BCom FCSA, Company Governance | |
| BS BS, Exec Counsel | |
| Paul BA, CEO MD | |
| Ethan Settembre, Vice Seqirus | |
| BCom BComm, Chief Officer | |
| BSc GAICD, Senior Research | |
| Dave Ross, Senior Seqirus | |
| Laurie MD, Vice Transplant | |
| Christina Hickie, Senior Communications | |
| Wilfried Freudenberg, Department Production | |
| MS BA, Ex Officer | |
| Roanne Parry, Chief Officer | |
| Karen Etchberger, Executive Services | |
| Jemimah Brennan, Head Pacific | |
| Mark Dehring, Head Relations | |
| MPH MD, Executive Development | |
| John CPA, Interim Officer | |
CSL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CSL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for CSL Stock Analysis
When running CSL's price analysis, check to
measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to
predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.